Asgard Therapeutics AB
Pioneering in vivo cell reprogramming for next-generation cancer immunotherapy.
Oversikt
- 10–19
- Ansatte
- ≤1t SEK
- Omsetning
- 2018
- Grunnlagt
Nøkkelbeslutningstakere
Philipp Müller
Board Member (Boehringer Ingelheim Venture Fund)
Ignacio Melero
Clinical Advisory Board Member
Johanna Olweus
Scientific Advisory Board Member
Shane Olwill
Chief Development Officer
+15 flere kontakter i Funnelfeedr
Beskrivelse
Asgard Therapeutics is a Swedish private biotech company focused on revolutionizing cancer immunotherapy. Their core mission involves pioneering direct cell reprogramming technologies. Specifically, they aim to develop scalable methods for the in vivo conversion of cancer cells into functional antig...